Cell and Gene Therapy - International Biopharmaceutical Industry

news

Streamlining IND Applications for Cell and Gene Therapy Innovations

Cell and gene therapies (CGTs) are quickly emerging as valuable approaches for the treatment of complex diseases. The development of these treatments, especially Adv...

23 September 2024 news Cell and Gene Therapy | Regulatory

Continue Reading →

news

4D Molecular Data ‘Bode Well’ for Eye Gene Therapy, but Shares Fall

Shares dropped by double-digits after the biotech shared longer-term results for a gene therapy it’s developing for a common form of macular degeneration. Outline...

23 September 2024 news Cell and Gene Therapy

Continue Reading →

news

Gilead’s Kite Exits China Cell Therapy Joint Venture with Fosun Pharma

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the 50-50 cell-therapy-focused joint venture wi...

23 September 2024 news CAR-T cells | Cell and Gene Therapy

Continue Reading →

Volume 4 Issue 4

CGT CDMO Partnering: More than just Manufacturing

The biotech footprint has been exponentially expanding around the globe and no division has increased more feverishly in recent years than the Cell and Gene Therapy (...